Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Pankaj R Patel has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201118-11-2016
18-11-2016
Cadila to transfer India human formulations business to Zydus
The India human formulations business, including a manufacturing plant at GIDC, Ahmedabad and pharmaceutical technology centre in Ahmedabad will be transferred to Zydus17-11-2016
Investor Presentation
Zydus Wellness Ltd has submitted to BSE a copy of the investor presentation to be made by Mr. Tarun G. Arora, Whole Time Director and Mr. Amit B. Jain, Chief Financial Officer of the Company to the select investors on November 16, 2016 in Grand Hyatt, Kalina, Mumbai.15-11-2016
Zydus Wellness Q2 Net up 10.2% to Rs 32 crore
Gross margins increased by 140 basis points and reached 66.8 per cent25-10-2016
Results Press Release for September 30, 2016
Zydus Wellness Ltd has informed BSE about : 1. Result Press Release for the period ended September 30, 201625-10-2016
Standalone & Consolidated Financial Results, Limited Review Report for September 30, 2016
Zydus Wellness Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Consolidated Financial Results for the period ended September 30, 20163. Standalone Limited Review for the period ended September 30, 20164. Consolidated Limited Review for the period ended September 30, 201625-10-2016
Intimation of Schedule of Analyst / Institutional Investor Meetings
Zydus Wellness Ltd has informed BSE about Schedule of Analyst / Institutional Investor Meet19-10-2016
Zydus Wellness independent director B M Hegde resigns
Zydus Group firm Zydus Wellness today said its independent director B M Hegde has resigned due to personal reasons. Dr B M Hegde, an independent director of the company, has resigned with immediate...15-10-2016
Resignation of Independent Director
Zydus Wellness Ltd has informed BSE that Dr. B. M. Hegde, an Independent Director of the Company has resigned with immediate effect due to personal reasons. Pursuant to his resignation, he also ceased to be the member of the Committees of the Board of Directors, in which he was a member.The Directors, vide Circular Resolution, have accepted the resignation.15-10-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Zydus Wellness Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.08-10-2016